These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18351504)

  • 1. [Safety of cardiac pacemakers and implantable cardioverter-defibrillators in magnetic resonance imaging. Assessment of the aggregate function at 1.5 tesla].
    Nordbeck P; Bauer WR
    Dtsch Med Wochenschr; 2008 Mar; 133(13):624-8. PubMed ID: 18351504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro tests reveal sample radiofrequency identification readers inducing clinically significant electromagnetic interference to implantable pacemakers and implantable cardioverter-defibrillators.
    Seidman SJ; Brockman R; Lewis BM; Guag J; Shein MJ; Clement WJ; Kippola J; Digby D; Barber C; Huntwork D
    Heart Rhythm; 2010 Jan; 7(1):99-107. PubMed ID: 20129290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficiency of low-field magnetic resonance imaging in patients with cardiac rhythm management devices.
    Schukro C; Puchner SB
    Eur J Radiol; 2019 Sep; 118():96-100. PubMed ID: 31439265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not all pacemakers are created equal: MRI conditional pacemaker and lead technology.
    Ahmed FZ; Morris GM; Allen S; Khattar R; Mamas M; Zaidi A
    J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1059-65. PubMed ID: 24016320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging in Nondependent Pacemaker Patients with Pacemakers and Defibrillators with a Nearly Depleted Battery.
    Okamura H; Padmanabhan D; Watson RE; Dalzell C; Acker N; Jondal M; Romme AL; Cha YM; Asirvatham SJ; Felmlee JP; Friedman PA
    Pacing Clin Electrophysiol; 2017 May; 40(5):476-481. PubMed ID: 28169434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR Imaging in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators.
    Sommer T; Bauer W; Fischbach K; Kolb C; Luechinger R; Wiegand U; Lotz J; Eitel I; Gutberlet M; Thiele H; Schild HH; Kelm M; Quick HH; Schulz-Menger J; Barkhausen J; Bänsch D
    Rofo; 2017 Mar; 189(3):204-217. PubMed ID: 28201839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety of magnetic resonance imaging in patients with pacemaker and implantable defibrillator].
    Al-Sabagh KH; Christensen BE; Thøgersen AM; Petersen HH; Videbaek R; Pehrson S; Chen X; Thomsen C; Svendsen JH
    Ugeskr Laeger; 2010 Jun; 172(23):1740-4. PubMed ID: 20534201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.
    Dandamudi S; Collins JD; Carr JC; Mongkolwat P; Rahsepar AA; Tomson TT; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Acad Radiol; 2016 Dec; 23(12):1498-1505. PubMed ID: 27717762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of MRI in Patients With Implanted Pacemakers and Implantable Cardioverter-Defibrillators Across a Cross Population: Does the Benefit Justify the Risk? A Proof of Concept Study.
    Samar H; Yamrozik JA; Williams RB; Doyle M; Shah M; Bonnet CA; Biederman RWW
    JACC Clin Electrophysiol; 2017 Sep; 3(9):991-1002. PubMed ID: 29759724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.
    Russo RJ
    Am Heart J; 2013 Mar; 165(3):266-72. PubMed ID: 23453091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan.
    Mollerus M; Albin G; Lipinski M; Lucca J
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):772-8. PubMed ID: 19545340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromagnetic interference with cardiac pacemakers and implantable cardioverter-defibrillators from low-frequency electromagnetic fields in vivo.
    Tiikkaja M; Aro AL; Alanko T; Lindholm H; Sistonen H; Hartikainen JE; Toivonen L; Juutilainen J; Hietanen M
    Europace; 2013 Mar; 15(3):388-94. PubMed ID: 23125355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports.
    Maisel WH; Moynahan M; Zuckerman BD; Gross TP; Tovar OH; Tillman DB; Schultz DB
    JAMA; 2006 Apr; 295(16):1901-6. PubMed ID: 16639048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study.
    Zaremba T; Jakobsen AR; Søgaard M; Thøgersen AM; Johansen MB; Madsen LB; Riahi S
    Pacing Clin Electrophysiol; 2015 Mar; 38(3):343-56. PubMed ID: 25601489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference between dental electrical devices and pacemakers or defibrillators: results from a prospective clinical study.
    Elayi CS; Lusher S; Meeks Nyquist JL; Darrat Y; Morales GX; Miller CS
    J Am Dent Assoc; 2015 Feb; 146(2):121-8. PubMed ID: 25637210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in patients with cardiac implantable electronic devices: a single-center prospective study.
    Yadava M; Nugent M; Krebsbach A; Minnier J; Jessel P; Henrikson CA
    J Interv Card Electrophysiol; 2017 Oct; 50(1):95-104. PubMed ID: 28733766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator.
    Lupo P; Cappato R; Di Leo G; Secchi F; Papini GDE; Foresti S; Ali H; De Ambroggi GMG; Sorgente A; Epicoco G; Cannaò PM; Sardanelli F
    Eur Radiol; 2018 Jun; 28(6):2406-2416. PubMed ID: 29318430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac pacemakers and implantable cardioverter defibrillators: in vitro magnetic resonance imaging evaluation at 1.5-tesla.
    Shellock FG; Fischer L; Fieno DS
    J Cardiovasc Magn Reson; 2007; 9(1):21-31. PubMed ID: 17178677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.